{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:58:59Z","timestamp":1778237939876,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"ALF Grant, \u00d6sterg\u00f6tland County Council","award":["LIO-698411"],"award-info":[{"award-number":["LIO-698411"]}]},{"DOI":"10.13039\/501100009776","name":"Region\u00a0G\u00e4vleborg","doi-asserted-by":"publisher","award":["CFUG-651191"],"award-info":[{"award-number":["CFUG-651191"]}],"id":[{"id":"10.13039\/501100009776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00198-019-05249-3","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T22:13:51Z","timestamp":1578953631000},"page":"951-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased rate of reoperation in atypical femoral fractures is related to patient characteristics and not fracture type. A nationwide cohort study"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-1064","authenticated-orcid":false,"given":"H.P.","family":"B\u00f6gl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2815-1217","authenticated-orcid":false,"given":"K.","family":"Micha\u00eblsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-2983","authenticated-orcid":false,"given":"G.","family":"Zdolsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0012-1211","authenticated-orcid":false,"given":"J.","family":"H\u00f6ijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-9265","authenticated-orcid":false,"given":"J.","family":"Schilcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"5249_CR1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","volume":"86","author":"J Schilcher","year":"2015","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Michaelsson K (2015) Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop 86:100\u2013107","journal-title":"Acta Orthop"},{"key":"5249_CR2","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.2565","volume":"30","author":"S Jha","year":"2015","unstructured":"Jha S, Wang Z, Laucis N, Bhattacharyya T (2015) Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis. J Bone Miner Res 30:2179\u20132187","journal-title":"J Bone Miner Res"},{"key":"5249_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"5249_CR4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2106\/JBJS.K.01181","volume":"95","author":"BJ Edwards","year":"2013","unstructured":"Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, McKoy J, Omar I, Belknap SM, Garg V, Hahr AJ, Samaras AT, Fisher MJ, West DP, Langman CB, Stern PH (2013) Bisphosphonates and nonhealing femoral fractures: analysis of the FDA adverse event reporting system (FAERS) and international safety efforts: a systematic review from the research on adverse drug events and reports (RADAR) project. J Bone Joint Surg Am 95:297\u2013307","journal-title":"J Bone Joint Surg Am"},{"key":"5249_CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00002018-200932090-00002","volume":"32","author":"K Ing-Lorenzini","year":"2009","unstructured":"Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R (2009) Low-energy femoral fractures associated with the long-term use of bisphosphonates. Drug Saf 32:775\u2013785","journal-title":"Drug Saf"},{"key":"5249_CR6","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"key":"5249_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/BOT.0000000000000516","volume":"30","author":"Y Bogdan","year":"2016","unstructured":"Bogdan Y, Tornetta P 3rd, Einhorn TA et al (2016) Healing time and complications in operatively treated atypical femur fractures associated with bisphosphonate use: a multicenter retrospective cohort. J Orthop Trauma 30:177\u2013181","journal-title":"J Orthop Trauma"},{"key":"5249_CR8","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1007\/s11999-013-2963-1","volume":"472","author":"KA Egol","year":"2014","unstructured":"Egol KA, Park JH, Rosenberg ZS, Peck V, Tejwani NC (2014) Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails. Clin Orthop Relat Res 472:2728\u20132734","journal-title":"Clin Orthop Relat Res"},{"key":"5249_CR9","doi-asserted-by":"publisher","unstructured":"O'Neill BJ, O'HEireamhoin S, Morrissey DI, Keogh P (2014) Implant failure caused by non-union of bisphosphonate-associated subtrochanteric femur fracture. BMJ Case Rep 2014. https:\/\/doi.org\/10.1136\/bcr-2013-203519","DOI":"10.1136\/bcr-2013-203519"},{"key":"5249_CR10","first-page":"31","volume":"61","author":"JP Schneider","year":"2006","unstructured":"Schneider JP (2006) Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate. Geriatrics 61:31\u201333","journal-title":"Geriatrics"},{"key":"5249_CR11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/TA.0b013e31821957e3","volume":"71","author":"YA Weil","year":"2011","unstructured":"Weil YA, Rivkin G, Safran O, Liebergall M, Foldes AJ (2011) The outcome of surgically treated femur fractures associated with long-term bisphosphonate use. J Trauma 71:186\u2013190","journal-title":"J Trauma"},{"key":"5249_CR12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1302\/0301-620X.96B5.32887","volume":"96-B","author":"BJ Teo","year":"2014","unstructured":"Teo BJ, Koh JS, Goh SK, Png MA, Chua DT, Howe TS (2014) Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy. Bone Joint J 96-B:658\u2013664","journal-title":"Bone Joint J"},{"key":"5249_CR13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.injury.2017.02.036","volume":"48","author":"KJ Lee","year":"2017","unstructured":"Lee KJ, Yoo JJ, Oh KJ, Yoo JH, Rhyu KH, Nam KW, Suh DH (2017) Surgical outcome of intramedullary nailing in patients with complete atypical femoral fracture: a multicenter retrospective study. Injury 48:941\u2013945","journal-title":"Injury"},{"key":"5249_CR14","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0020-1383(16)30015-8","volume":"47","author":"SL Kates","year":"2016","unstructured":"Kates SL, Ackert-Bicknell CL (2016) How do bisphosphonates affect fracture healing? Injury 47:S65\u2013S68","journal-title":"Injury"},{"key":"5249_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00402-012-1558-8","volume":"134","author":"S Larsson","year":"2014","unstructured":"Larsson S, Fazzalari NL (2014) Anti-osteoporosis therapy and fracture healing. Arch Orthop Trauma Surg 134:291\u2013297","journal-title":"Arch Orthop Trauma Surg"},{"key":"5249_CR16","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00198-017-4058-4","volume":"28","author":"HP Bogl","year":"2017","unstructured":"Bogl HP, Aspenberg P, Schilcher J (2017) Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series. Osteoporos Int 28:2439\u20132444","journal-title":"Osteoporos Int"},{"key":"5249_CR17","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","volume":"364","author":"J Schilcher","year":"2011","unstructured":"Schilcher J, Michaelsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364:1728\u20131737","journal-title":"N Engl J Med"},{"key":"5249_CR18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11914-018-0464-6","volume":"16","author":"J Starr","year":"2018","unstructured":"Starr J, Tay YKD, Shane E (2018) Current understanding of epidemiology, pathophysiology, and management of atypical femur fractures. Curr Osteoporos Rep 16:519\u2013529","journal-title":"Curr Osteoporos Rep"},{"key":"5249_CR19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jbmr.2767","volume":"31","author":"M Kharazmi","year":"2016","unstructured":"Kharazmi M, Hallberg P, Schilcher J, Aspenberg P, Michaelsson K (2016) Mortality after atypical femoral fractures: a cohort study. J Bone Miner Res 31:491\u2013497","journal-title":"J Bone Miner Res"},{"key":"5249_CR20","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2106\/JBJS.G.01580","volume":"90","author":"LA Corrales","year":"2008","unstructured":"Corrales LA, Morshed S, Bhandari M, Miclau T 3rd (2008) Variability in the assessment of fracture-healing in orthopaedic trauma studies. J Bone Joint Surg Am 90:1862\u20131868","journal-title":"J Bone Joint Surg Am"},{"key":"5249_CR21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJMc1403799","volume":"371","author":"J Schilcher","year":"2014","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Michaelsson K (2014) Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med 371:974\u2013976","journal-title":"N Engl J Med"},{"key":"5249_CR22","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMe1003064","volume":"362","author":"E Shane","year":"2010","unstructured":"Shane E (2010) Evolving data about subtrochanteric fractures and bisphosphonates. N Engl J Med 362:1825\u20131827","journal-title":"N Engl J Med"},{"key":"5249_CR23","doi-asserted-by":"publisher","unstructured":"Fielding JW (1973) Subtrochanteric fractures. Clin Orthop Relat Res (92): 86-99. https:\/\/doi.org\/10.1097\/00003086-197305000-00008","DOI":"10.1097\/00003086-197305000-00008"},{"key":"5249_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00005373-199708000-00010","volume":"43","author":"CC Wu","year":"1997","unstructured":"Wu CC (1997) The effect of dynamization on slowing the healing of femur shaft fractures after interlocking nailing. J Trauma 43:263\u2013267","journal-title":"J Trauma"},{"key":"5249_CR25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/17453679708999022","volume":"68","author":"CC Wu","year":"1997","unstructured":"Wu CC, Chen WJ (1997) Healing of 56 segmental femoral shaft fractures after locked nailing. Poor results of dynamization. Acta Orthop Scand 68:537\u2013540","journal-title":"Acta Orthop Scand"},{"key":"5249_CR26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.injury.2011.06.024","volume":"42","author":"C Papakostidis","year":"2011","unstructured":"Papakostidis C, Psyllakis I, Vardakas D, Grestas A, Giannoudis PV (2011) Femoral-shaft fractures and nonunions treated with intramedullary nails: the role of dynamisation. Injury 42:1353\u20131361","journal-title":"Injury"},{"key":"5249_CR27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11:450","journal-title":"BMC Public Health"},{"key":"5249_CR28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130\u20131139","journal-title":"Med Care"},{"key":"5249_CR29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10654-017-0325-0","volume":"33","author":"MA Mansournia","year":"2018","unstructured":"Mansournia MA, Jewell NP, Greenland S (2018) Case-control matching: effects, misconceptions, and recommendations. Eur J Epidemiol 33:5\u201314","journal-title":"Eur J Epidemiol"},{"key":"5249_CR30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pmrj.2009.11.007","volume":"2","author":"RD Bunning","year":"2010","unstructured":"Bunning RD, Rentfro RJ, Jelinek JS (2010) Low-energy femoral fractures associated with long-term bisphosphonate use in a rehabilitation setting: a case series. PM R 2:76\u201380","journal-title":"PM R"},{"key":"5249_CR31","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2007-2803","volume":"93","author":"M Visekruna","year":"2008","unstructured":"Visekruna M, Wilson D, McKiernan FE (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93:2948\u20132952","journal-title":"J Clin Endocrinol Metab"},{"key":"5249_CR32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/17453670710015580","volume":"79","author":"AS Sayed-Noor","year":"2008","unstructured":"Sayed-Noor AS, Sjoden GO (2008) Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy--a case report. Acta Orthop 79:565\u2013567","journal-title":"Acta Orthop"},{"key":"5249_CR33","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1359\/jbmr.090408","volume":"24","author":"MP Somford","year":"2009","unstructured":"Somford MP, Draijer FW, Thomassen BJ, Chavassieux PM, Boivin G, Papapoulos SE (2009) Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility. J Bone Miner Res 24:1736\u20131740","journal-title":"J Bone Miner Res"},{"key":"5249_CR34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jor.20395","volume":"25","author":"JG Barrett","year":"2007","unstructured":"Barrett JG, Sample SJ, McCarthy J, Kalscheur VL, Muir P, Prokuski L (2007) Effect of short-term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats. J Orthop Res 25:1070\u20131077","journal-title":"J Orthop Res"},{"key":"5249_CR35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/jor.21464","volume":"29","author":"LJ Kidd","year":"2011","unstructured":"Kidd LJ, Cowling NR, Wu AC, Kelly WL, Forwood MR (2011) Bisphosphonate treatment delays stress fracture remodeling in the rat ulna. J Orthop Res 29:1827\u20131833","journal-title":"J Orthop Res"},{"key":"5249_CR36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.injury.2016.10.035","volume":"48","author":"KS Khow","year":"2017","unstructured":"Khow KS, Paterson F, Shibu P, Yu SC, Chehade MJ, Visvanathan R (2017) Outcomes between older adults with atypical and typical femoral fractures are comparable. Injury 48:394\u2013398","journal-title":"Injury"},{"key":"5249_CR37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3113\/JSOA.2018.0014","volume":"27","author":"DS Schultz","year":"2018","unstructured":"Schultz DS, Gass HM, Barfield WR, Demos HA, Hartsock LA (2018) Surgical complications associated with atypical femur fractures attributed to bisphosphonate use. J Surg Orthop Adv 27:14\u201320","journal-title":"J Surg Orthop Adv"},{"key":"5249_CR38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1302\/0301-620X.94B3.27999","volume":"94","author":"RN Thompson","year":"2012","unstructured":"Thompson RN, Phillips JR, McCauley SH, Elliott JR, Moran CG (2012) Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals. J Bone Joint Surg British 94:385\u2013390","journal-title":"J Bone Joint Surg British"},{"key":"5249_CR39","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s00198-018-4640-4","volume":"29","author":"SJ Lim","year":"2018","unstructured":"Lim SJ, Yeo I, Yoon PW, Yoo JJ, Rhyu KH, Han SB, Lee WS, Song JH, Min BW, Park YS (2018) Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study. Osteoporos Int 29:2427\u20132435","journal-title":"Osteoporos Int"},{"key":"5249_CR40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ans.12018","volume":"83","author":"J Shkolnikova","year":"2013","unstructured":"Shkolnikova J, Flynn J, Choong P (2013) Burden of bisphosphonate-associated femoral fractures. ANZ J Surg 83:175\u2013181","journal-title":"ANZ J Surg"},{"key":"5249_CR41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jbmr.2801","volume":"31","author":"B Abrahamsen","year":"2016","unstructured":"Abrahamsen B, Prieto-Alhambra D (2016) Patients with atypical femur fractures have the same mortality as the background population--drug-channeling bias, bisphosphonate effects, and public health implications. J Bone Miner Res 31:488\u2013490","journal-title":"J Bone Miner Res"},{"key":"5249_CR42","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00264-013-2259-9","volume":"38","author":"JS Kang","year":"2014","unstructured":"Kang JS, Won YY, Kim JO, Min BW, Lee KH, Park KK, Song JH, Kim YT, Kim GH (2014) Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study. Int Orthop 38:1247\u20131253","journal-title":"Int Orthop"},{"key":"5249_CR43","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/jbmr.2547","volume":"30","author":"J Schilcher","year":"2015","unstructured":"Schilcher J, Howe TS, Png MA, Aspenberg P, Koh JS (2015) Atypical fractures are mainly subtrochanteric in Singapore and diaphyseal in Sweden: a cross-sectional study. J Bone Miner Res 30:2127\u20132132","journal-title":"J Bone Miner Res"},{"key":"5249_CR44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","volume":"85","author":"JC Lo","year":"2016","unstructured":"Lo JC, Hui RL, Grimsrud CD, Chandra M, Neugebauer RS, Gonzalez JR, Budayr A, Lau G, Ettinger B (2016) The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone 85:142\u2013147","journal-title":"Bone"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05249-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05249-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05249-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T21:59:29Z","timestamp":1610488769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05249-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5249"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05249-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]},"assertion":[{"value":"7 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}